© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Takeda Pharmaceutical Company Limited (TAK) shows an Average True Range (ATR) of 0.3 and an Enterprise Value of 10.83T. Its average trading volume over the past 3 months is 2.91M, indicating liquidity. These fundamental metrics provide insight into TAK's underlying financial health and market activity.
| ATR | 0.3 |
| Enterprise Value | 10.83T |
| Avg Vol (3 Months) | 2.91M |
| Avg Vol (10 Days) | 2.53M |
Takeda Pharmaceutical Company Limited (TAK) technical indicators as of February 11, 2026: the SMA 20 is 7.03%, SMA 50 at 14.59%, and SMA 200 at 21.37%. The RSI 14 value is 76.75, suggesting its current momentum. These technical analysis signals help assess TAK's price trends and potential future movements.
| SMA 20 | 7.03% |
| SMA 50 | 14.59% |
| SMA 200 | 21.37% |
| RSI 14 | 76.75 |
Takeda Pharmaceutical Company Limited (TAK) stock performance overview as of February 11, 2026: The 52-week high is $18.16 (currently 0.64% below), and the 52-week low is $12.99 (currently 39.34% above). Over the past year, TAK's performance is 23.75%, compared to the S&P 500's 8.87% change.
| 52-Week High | 18.16 |
| 52-Week High Chg | +0.64% |
| 52-Week Low | 12.99 |
| 52-Week Low Chg | +39.34% |
| S&P 500 52-Week Chg | 8.87% |
According to market data, Takeda Pharmaceutical Company Limited (TAK) stock's recent performance metrics show that over the last month, TAK is 11.61%, with a Year-to-Date (YTD) performance of 3.59%. Over the past year, the stock has seen a 23.75% change. These figures summarize TAK's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 18.16 | 18.16 | 18.16 | 18.16 | 18.16 | 18.16 |
| Low | 17.58 | 15.78 | 13.56 | 12.99 | 12.99 | 15.48 |
| Performance | -0.68% | +11.61% | +15.03% | +11.84% | +23.75% | +3.59% |
According to current financial data, TAK stock's P/E (TTM) ratio is 77.07, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for TAK, including P/S (1.97), P/B (1.16), and P/FCF (9.24), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | TAK | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 77.07 | -1.23 | 13.14 | 32.59 |
| P/S (TTM) | 1.97 | 3.71 | 6.11 | 5.98 |
| P/B (TTM) | 1.16 | 1275.89 | 22.43 | 5.42 |
| P/FCF (TTM) | 9.24 | -8.61 | -2.53 | 31.77 |